News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,238 Results
Type
Article (87706)
Company Profile (824)
Press Release (777695)
Multimedia
Podcasts (184)
Webinars (28)
Section
Business (233159)
Career Advice (4142)
Deals (39827)
Drug Delivery (144)
Drug Development (91338)
Employer Resources (203)
FDA (18341)
Job Trends (17414)
News (397657)
Policy (39945)
Tag
Academia (3006)
Academic (2)
Accelerated approval (24)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (163)
Alzheimer's disease (1749)
Antibody-drug conjugate (ADC) (299)
Approvals (18425)
Artificial intelligence (569)
Autoimmune disease (126)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (184)
Biotechnology (487)
Bladder cancer (149)
Brain cancer (59)
Breast cancer (569)
Cancer (4540)
Cardiovascular disease (401)
Career advice (3564)
Career pathing (39)
CAR-T (281)
CDC (59)
Cell therapy (764)
Cervical cancer (36)
Clinical research (76336)
Collaboration (1554)
Company closure (5)
Compensation (1046)
Complete response letters (64)
COVID-19 (2973)
CRISPR (92)
C-suite (717)
Cystic fibrosis (145)
Data (5596)
Decentralized trials (2)
Denatured (67)
Depression (129)
Diabetes (488)
Diagnostics (7153)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (218)
Earnings (99864)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134367)
Executive appointments (1008)
FDA (21124)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1410)
Gene editing (199)
Generative AI (57)
Gene therapy (609)
GLP-1 (1075)
Government (5415)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (269)
Immuno-oncology (31)
Indications (71)
Infectious disease (3239)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (110)
Intellectual property (212)
Interviews (816)
IPO (17941)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (651)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (638)
Lymphoma (344)
Machine learning (37)
Management (66)
Manufacturing (722)
MASH (164)
Medical device (14958)
Medtech (14996)
Mergers & acquisitions (22854)
Metabolic disorders (1267)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (310)
Neuropsychiatric disorders (81)
Neuroscience (2920)
NextGen: Class of 2025 (7703)
Non-profit (5101)
Now hiring (61)
Obesity (603)
Opinion (324)
Ovarian cancer (150)
Pain (181)
Pancreatic cancer (195)
Parkinson's disease (264)
Partnered (34)
Patents (457)
Patient recruitment (381)
Peanut (58)
People (66575)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23561)
Phase II (33135)
Phase III (24966)
Pipeline (3654)
Policy (317)
Postmarket research (3554)
Preclinical (10642)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (775)
Real estate (7434)
Recruiting (80)
Regulatory (28454)
Reports (65)
Research institute (2713)
Resumes & cover letters (651)
Rett syndrome (22)
RNA editing (16)
RSV (82)
Schizophrenia (145)
Series A (228)
Series B (175)
Service/supplier (30)
Sickle cell disease (94)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (115)
Vaccines (1094)
Venture capital (76)
Weight loss (423)
Women's health (73)
Worklife (21)
Date
Today (137)
Last 7 days (737)
Last 30 days (2823)
Last 365 days (33423)
2025 (31774)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (83)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (51258)
Australia (9009)
California (10648)
Canada (3122)
China (1024)
Colorado (449)
Connecticut (477)
Delaware (319)
Europe (117856)
Florida (1562)
Georgia (343)
Hawaii (3)
Idaho (68)
Illinois (880)
India (61)
Indiana (511)
Iowa (22)
Japan (365)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1389)
Massachusetts (7908)
Michigan (336)
Minnesota (616)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (116)
New Hampshire (81)
New Jersey (2916)
New Mexico (32)
New York (2855)
North Carolina (1521)
North Dakota (10)
Northern California (4991)
Ohio (322)
Oklahoma (22)
Oregon (52)
Pennsylvania (2168)
Puerto Rico (20)
Rhode Island (47)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4095)
Tennessee (164)
Texas (1664)
United States (38807)
Utah (319)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (897)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
There are 866,238 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
GSK Cuts Five-Year-Old Cancer Collaboration With Ideaya
GSK and Ideaya first linked up in 2020 to advance novel therapies for solid tumors. It is unclear why the pharma terminated the partnership.
December 8, 2025
·
2 min read
·
Tristan Manalac
Neuroscience
Biogen, Stoke Boost Epilepsy Drug’s Blockbuster Potential With Early Seizure Reduction Data
Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 billion to $4 billion.
December 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial
December 8, 2025
·
7 min read
Press Releases
Hercules Pharmaceuticals Approved as Authorized Distributor in Apexus 340B Prime Vendor Program
December 8, 2025
·
3 min read
Press Releases
Faron Presents Updated BEXMAB Data at ASH 2025: Deep and Durable Responses in HR-MDS with Favorable Safety Profile
December 8, 2025
·
7 min read
Press Releases
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL
December 8, 2025
·
4 min read
Press Releases
Appointment of Francis Van Parys as Chief Executive Officer
December 8, 2025
·
3 min read
Press Releases
Ascletis’ Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight
December 8, 2025
·
7 min read
Press Releases
Servier’s Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions
December 8, 2025
·
2 min read
Press Releases
Nomination Committee Appointed for Spago Nanomedical’s Annual General Meeting 2026
December 8, 2025
·
1 min read
1 of 86,624
Next
